Drug TreatmentsDrug treatment by gonadorelin analoguesThere are a number of drugs that are used for this treatment:
These drugs mimic menopause by blocking the hormone (gonadotrophin releasing hormone) that is responsible for the production of oestrogen, ampoule the female hormone. These are known as gonadorelin analogues. They induce rapid menopause by blocking oestrogen production with the result that the blood levels to the fibroid drop and the fibroids get smaller, as they would after menopause. This is only a temporary treatment for fibroids, sometimes used to reduce them before surgery or menopause. However, drugs should not be used for longer than 6 months and should not be repeated. The side effects are menopausal-like - hot flushes, increased sweating, vaginal dryness, loss of libido, osteoporosis, mood swings, memory loss and hypersensitivity reactions. Some gynaecologists will not use these drugs, as the side effects are so unpleasant. When drug treatment stops the fibroids return to their pre-treatment size within 24 weeks. Read our Drug Treatments FAQs |
You are here:
Our Survey and Guidelines
NICE Review of their Clinical Guidlines on Heavy Menstrual Bleeding carried out by part of RCOG is launched 14th March'18. FEmISA condemns it as unsafe for women - see our press release. FEmISA queries NICE's figures on hysteroscopy. This is regressive - see our concerns and our submission to this NICE eEview.
See FEmISA's new report on NICE compliance and patient choice for fibroid treatments part of this report was included in the recent APPG On Women's Health report Informed Choice? Giving women control of their healthcare
Thanks to all who took part in our survey about the information and choices for their fibroid treatment. Please click here for the Patient Information and Choice Survey report and here for our report on access to UFE treatment with The Medical Technology Group and All Party Parliamentary Group on Improving Patient Access to Medical Technologies.